ES2058094T3 - Interferon-gamma de caballo. - Google Patents

Interferon-gamma de caballo.

Info

Publication number
ES2058094T3
ES2058094T3 ES87118264T ES87118264T ES2058094T3 ES 2058094 T3 ES2058094 T3 ES 2058094T3 ES 87118264 T ES87118264 T ES 87118264T ES 87118264 T ES87118264 T ES 87118264T ES 2058094 T3 ES2058094 T3 ES 2058094T3
Authority
ES
Spain
Prior art keywords
gamma
interferon
horse
eqifn
polypeptide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES87118264T
Other languages
English (en)
Inventor
Rudolf Dr Hauptmann
Adolf Dr Dipl-Ing Himmler
Peter Prof Dr Swetly
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Boehringer Ingelheim International GmbH
Original Assignee
Boehringer Ingelheim International GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim International GmbH filed Critical Boehringer Ingelheim International GmbH
Application granted granted Critical
Publication of ES2058094T3 publication Critical patent/ES2058094T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/24—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
    • C07K16/249—Interferons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/555—Interferons [IFN]
    • C07K14/57—IFN-gamma
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Immunology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)

Abstract

EL OBJETO DE LA PRESENTE INVENCION ES UN PROCEDIMIENTO PARA LA OBTENCION DE GAMMA-INTERFERON DE CABALLO (GAMMA- INTERFERON EQUINO, EQIFN-GAMMA), SECUENCIAS DE ADN QUE CODIFICAN ESTE POLIPEPTIDO, VECTORES Y ORGANISMOS-HUESPEDES QUE CONTIENEN DICHAS SECUENCIAS DE ADN ASI COMO AL PROPIO EQIFN-GAMMA. SON, ADEMAS, OBJETO DE LA INVENCION LAS SECUENCIAS PARCIALES DE ADN QUE CODIFICAN POLIPEPTIDOS QUE SE DIFERENCIAN ESTRUCTURALMENTE DEL POLIPEPTIDO DEL EQIFN-GAMMA. APARTE DE ESTO SE DESCRIBE LA APLICACION DE LAS PROTEINAS.
ES87118264T 1986-12-10 1987-12-09 Interferon-gamma de caballo. Expired - Lifetime ES2058094T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19863642096 DE3642096A1 (de) 1986-12-10 1986-12-10 Pferde-(gamma)-interferon

Publications (1)

Publication Number Publication Date
ES2058094T3 true ES2058094T3 (es) 1994-11-01

Family

ID=6315829

Family Applications (1)

Application Number Title Priority Date Filing Date
ES87118264T Expired - Lifetime ES2058094T3 (es) 1986-12-10 1987-12-09 Interferon-gamma de caballo.

Country Status (20)

Country Link
US (1) US5602010A (es)
EP (1) EP0271824B1 (es)
JP (3) JPS63233794A (es)
KR (1) KR880007568A (es)
AT (1) ATE91722T1 (es)
AU (1) AU616873B2 (es)
CA (1) CA1339776C (es)
DE (2) DE3642096A1 (es)
DK (1) DK170054B1 (es)
ES (1) ES2058094T3 (es)
FI (1) FI99116C (es)
HU (1) HU213566B (es)
IE (1) IE60404B1 (es)
IL (1) IL84780A (es)
NO (1) NO180239C (es)
NZ (1) NZ222856A (es)
PH (1) PH30889A (es)
PT (1) PT86332B (es)
SU (1) SU1701114A3 (es)
ZA (1) ZA879245B (es)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0041313B1 (en) 1980-04-03 1990-09-12 Biogen, Inc. Dna sequences, recombinant dna molecules and processes for producing human fibroblast interferon
US6307025B1 (en) 1989-04-28 2001-10-23 Biogen, Inc. VCAM fusion proteins and DNA coding therefor
US5272263A (en) * 1989-04-28 1993-12-21 Biogen, Inc. DNA sequences encoding vascular cell adhesion molecules (VCAMS)
US7049102B1 (en) 1989-09-22 2006-05-23 Board Of Trustees Of Leland Stanford University Multi-gene expression profile
GB9414752D0 (en) * 1994-07-21 1994-09-07 Q One Biotech Ltd Feline gamma-interferon
GB2291645A (en) * 1994-07-21 1996-01-31 Q One Biotech Ltd Equine gamma-interferon
IL155730A0 (en) * 2000-11-03 2003-11-23 Biomedicines Inc Method for short-term and long-term drug dosimetry
CA2466228A1 (en) * 2001-11-09 2003-08-07 Biomedicines, Inc. Method for treating diseases with omega interferon
US7731947B2 (en) 2003-11-17 2010-06-08 Intarcia Therapeutics, Inc. Composition and dosage form comprising an interferon particle formulation and suspending vehicle
WO2006083761A2 (en) 2005-02-03 2006-08-10 Alza Corporation Solvent/polymer solutions as suspension vehicles
US11246913B2 (en) 2005-02-03 2022-02-15 Intarcia Therapeutics, Inc. Suspension formulation comprising an insulinotropic peptide
KR101106510B1 (ko) 2006-05-30 2012-01-20 인타르시아 세라퓨틱스 인코포레이티드 투피스, 내부채널 삼투압 전달 시스템 유동 조절기
EP2359808B1 (en) 2006-08-09 2013-05-22 Intarcia Therapeutics, Inc Osmotic delivery systems and piston assemblies
WO2008133908A2 (en) 2007-04-23 2008-11-06 Intarcia Therapeutics, Inc. Suspension formulations of insulinotropic peptides and uses thereof
CA2726861C (en) 2008-02-13 2014-05-27 Intarcia Therapeutics, Inc. Devices, formulations, and methods for delivery of multiple beneficial agents
RU2547990C2 (ru) 2009-09-28 2015-04-10 Интарсия Терапьютикс, Инк. Быстрое достижение и/или прекращение существенной стабильной доставки лекарственного средства
US20120208755A1 (en) 2011-02-16 2012-08-16 Intarcia Therapeutics, Inc. Compositions, Devices and Methods of Use Thereof for the Treatment of Cancers
US9889085B1 (en) 2014-09-30 2018-02-13 Intarcia Therapeutics, Inc. Therapeutic methods for the treatment of diabetes and related conditions for patients with high baseline HbA1c
RU2730996C2 (ru) 2015-06-03 2020-08-26 Интарсия Терапьютикс, Инк. Системы установки и извлечения имплантата
KR102574993B1 (ko) 2016-05-16 2023-09-06 인타르시아 세라퓨틱스 인코포레이티드 글루카곤-수용체 선택적 폴리펩티드 및 이들의 이용 방법
USD860451S1 (en) 2016-06-02 2019-09-17 Intarcia Therapeutics, Inc. Implant removal tool
USD840030S1 (en) 2016-06-02 2019-02-05 Intarcia Therapeutics, Inc. Implant placement guide
JP7286542B2 (ja) 2017-01-03 2023-06-05 インターシア セラピューティクス，インコーポレイティド Ｇｌｐ－１受容体アゴニストの持続的投与及び薬物の同時投与を含む方法

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE88622C (es) *
ZA811368B (en) * 1980-03-24 1982-04-28 Genentech Inc Bacterial polypedtide expression employing tryptophan promoter-operator
ZA831094B (en) * 1982-02-22 1983-11-30 Biogen Nv Dna sequences,recombinant dna molecules and processes for producing human immune interferon-like polypeptides
IE54592B1 (en) * 1982-03-08 1989-12-06 Genentech Inc Anumal interferons, processes involved in their production, compositions containing them, dna sequences coding therefor and espression vehicles containing such sequences and cells transformed thereby
DE3247922A1 (de) * 1982-12-24 1984-06-28 Boehringer Ingelheim International GmbH, 6507 Ingelheim Dna-sequenzen, deren herstellung, diese sequenzen enthaltende plasmide und deren verwendung zur synthese eukaryotischer genprodukte in prokaryoten
JPS60118196A (ja) * 1983-11-30 1985-06-25 Takeda Chem Ind Ltd インタ−フェロンの製造法
US4666865A (en) * 1984-01-13 1987-05-19 Centocor, Inc. Immunoassay for biologically active human interferon-gamma employing unique monoclonal antibodies
DE3414831A1 (de) * 1984-04-19 1985-10-31 Hoechst Ag, 6230 Frankfurt Herstellung von polypeptiden mit human-gammainterferon-aktivitaet
FI90990C (fi) * 1984-12-18 1994-04-25 Boehringer Ingelheim Int Rekombinantti-DNA-molekyyli, transformoitu isäntäorganismi ja menetelmä interferonin valmistamiseksi
US4689224A (en) * 1985-10-07 1987-08-25 Neogen Corporation Method for administering vaccines containing equine leukokines and compositions therefor
DE3607835A1 (de) * 1986-03-10 1987-09-24 Boehringer Ingelheim Int Hybridinterferone, deren verwendung als arzneimittel und als zwischenprodukte zur herstellung von antikoerpern und deren verwendung sowie verfahren zu ihrer herstellung
CA1340698C (en) * 1986-07-25 1999-08-10 Kabushiki Kaisha Hayashibara Seibutsu Kaguku Kenkyujo Preparation and uses of interferon-gamma
US4908432A (en) * 1987-01-09 1990-03-13 New York University Novel polypeptide having gamma-interferon activity

Also Published As

Publication number Publication date
CA1339776C (en) 1998-03-24
IL84780A0 (en) 1988-05-31
PT86332B (pt) 1990-11-07
HU213566B (en) 1997-08-28
AU8223387A (en) 1988-06-30
FI99116B (fi) 1997-06-30
NO875136L (no) 1988-06-13
JPS63233794A (ja) 1988-09-29
JPH07250690A (ja) 1995-10-03
DK645887D0 (da) 1987-12-09
NO180239C (no) 1997-03-12
NZ222856A (en) 1991-11-26
PT86332A (de) 1988-01-01
SU1701114A3 (ru) 1991-12-23
AU616873B2 (en) 1991-11-14
EP0271824A2 (de) 1988-06-22
PH30889A (en) 1997-12-23
IE60404B1 (en) 1994-07-13
DE3642096A1 (de) 1988-06-16
KR880007568A (ko) 1988-08-27
IL84780A (en) 1992-11-15
HUT46066A (en) 1988-09-28
FI875427L (fi) 1988-06-11
JPH07258294A (ja) 1995-10-09
EP0271824A3 (en) 1989-05-24
US5602010A (en) 1997-02-11
EP0271824B1 (de) 1993-07-21
DE3786649D1 (de) 1993-08-26
NO180239B (no) 1996-12-02
ATE91722T1 (de) 1993-08-15
ZA879245B (en) 1989-08-30
IE873342L (en) 1988-06-10
NO875136D0 (no) 1987-12-09
DK645887A (da) 1988-06-11
FI99116C (fi) 1997-10-10
DK170054B1 (da) 1995-05-08
FI875427A0 (fi) 1987-12-10

Similar Documents

Publication Publication Date Title
ES2058094T3 (es) Interferon-gamma de caballo.
ES2083357T3 (es) Manganeso-superoxido-dismutasa humana (hmn-sod).
ATE182901T1 (de) Für androgen-rezeptor-protein kodierende dna
ES2056799T3 (es) Moleculas de adn codante para las regiones de control fmdh y gen estructural para una proteina que tiene una actividad de fmdh y su uso.
ES8705467A1 (es) Un procedimiento para producir la proteina apoacuorina
DK366483A (da) Gen, dna-transfervektor eller underenhed heraf, der koder for human preprorelaxin eller en underenhed deraf, fremgangsmaade til fremstilling af samme samt fremgangsmaade til fremstilling af human preprorelaxin eller en underenhed deraf
ES2087869T3 (es) Proteinas modificadas; interferones alfa y beta modificados, proteinas fosforiladas y analogos, secuencias de adn, y sus aplicaciones.
ATE116367T1 (de) Für antitumor-polypeptide kodierende dns, die polypeptide und diese polypeptide enthaltenden antitumor-wirkstoffe.
ATE121776T1 (de) Expression des biologisch aktiven faktors xiii.
ES2104596T3 (es) Nuevos polipeptidos, secuencias de adn que permiten su expresion, metodo de preparacion, y utilizacion.
NO882380L (no) Fibfonektin-bindende protein, samt fremstilling derav.
DE69025856D1 (de) Für ein protein mit der fähigkeit zur zusammenwirkung mit dem enhancer des alpha-fetoproteingens kodierende dna
ES2078925T3 (es) Proteinas de la estreptoquinasa, genes correspondientes, recombinantes plasmidicos correspondientes, transformantes correspondientes y procedimientos para su preparacion.
ES2091752T3 (es) Medios y procedimiento para la obtencion de un polipeptido de la interleucina-1 alfa humana, recombinante.
HU9500491D0 (en) Bordetella bronchiseptica vaccine
ES2059801T3 (es) Nuevas linfoquinas, secuencias de adn que codifican para estas linfoquinas, y composiciones farmaceuticas conteniendo estas linfoquinas.
ES553374A0 (es) Un procedimiento para mejorar la produccion de un polipeptido deseado en un hospedante transformado con una molecula de adn recombinantes.
ES2059717T3 (es) Nuevos polipeptidos y adn codante para estos.
PT84474B (pt) Processo para a preparacao de uma substancia proteica insecticida
ATE432985T1 (de) Polypeptide mit aktivität der stimulierung von neutrophilen

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 271824

Country of ref document: ES